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Abstract 
Objective: To better understand the structure of the Patient Assessment of Chronic Illness Care 
(PACIC) instrument. More specifically, to test all published validation models, using one single 
dataset and appropriate statistical tools. 
Design: Validation study using data from cross-sectional survey  
Participants: A population-based sample of non-institutionalized adults with diabetes residing 
in Switzerland (canton of Vaud).  
Main outcome measure:  French version of the 20-items PACIC instrument (5-point response 
scale). We conducted validation analyses using confirmatory factor analysis (CFA). The original 
five dimensions model and other published models were tested with three types of CFA: based 
i) on Pearson estimator of variance-covariance matrix, ii) on a polychoric correlation matrix and 
iii) on a likelihood estimation with a multinomial distribution for the manifest variables. All models 
were assessed using loadings and goodness of fit measures. 
Results: The analytical sample included 406 patients. Mean age was 64.4 years and 59% were 
men. Median of item responses varied between 1 and 4 (range 1-5), and range of missing 
values lied between 5.7% and 12.3%. Strong floor and ceiling effects were present. Even 
though loadings of the tested models were relatively high, the only model showing acceptable fit 
was the 11-items single dimension model. PACIC was associated to the expected variables of 
the field. 
Conclusions: Our results showed that the model considering 11 items in a single dimension 
fitted best our data. A single score, in complement to the consideration of single item results, 
might be used instead of the five dimensions usually described.  
Key words: Chronic care model, validation analyses, confirmatory factorial analysis, 
diabetes  
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Introduction 
The Chronic Care Model (CCM) was developed by Wagner et al. more than a decade ago [1,2]. 
This evidence-based framework identified six key elements likely to improve the care of patients 
with chronic illnesses: patient’s self-management, delivery system design, decision support, 
clinical information systems, community resources and policies, as well as organization of care. 
The Assessment of Chronic Illness Care (ACIC) [3] and Patient Assessment of Chronic Illness 
Care (PACIC) instruments were developed [4] to assess how chronic care was congruent with 
the CCM. While the ACIC was meant to be used by health care professionals, the PACIC was 
targeting the patients’ evaluation of their own chronic illness care.  
Initially developed in English [4], PACIC versions in Danish, Dutch, German and Spanish, tested 
in patients presenting diverse chronic diseases (e.g. diabetes, arthritis and chronic lung 
diseases), are available [4-15]. The literature review that we conducted to identify studies 
presenting validation analyses of the PACIC (Appendix A) showed contrasted results. While 
some studies seemed to confirm the five dimensions of the instrument (moderate to good 
internal consistency and most factor loadings>0.70), they either did not report goodness of fit of 
their models [5,6] or presented fits that were not acceptable [4,9]. In the first published English 
PACIC validation paper, Glasgow recommended the use of a unique PACIC global score given 
because “the intercorrelations among the PACIC scales and the high internal consistency of the 
total score” may make it difficult for respondents to recognize “differences among the subscale 
constructs” [4] . Recently, findings suggested a single [8,14] or a two dimensions structure 
[10,11]. Item reduction was even proposed to get a single dimension [7,12,14]. Despite the 
absence of consensus on the PACIC dimensions, its use has sharply increased as an 
evaluation tool of the development and implementation of chronic disease management 
initiatives. It has even been described as “the most appropriate instrument to measure the 
experience of people receiving integrated chronic care” [16]. 
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In this study, we aimed at deepening the understanding of the PACIC dimensional structure 
using statistical tools adapted to the ordinal structure. More specifically, we aimed at 
comprehensively describing previous validation analyses and at running all models tested in the 
literature on the same set of patients, using appropriate statistical models. This study should 
convey key information to decide which dimension structure is the most appropriate for this 
broadly used instrument.     
 
Methods 
Sample characteristics 
 
The study sample was constituted of 406 patients with diabetes who participated in a 
community-based survey describing the quality of their care [17]. This baseline survey was 
conducted within the development and implementation of a regional diabetes program 
(“Programme cantonal Diabète”) in the canton of Vaud, Switzerland, a large French-speaking 
canton with over 720,000 inhabitants (approximately one tenth of the Swiss population). Non-
institutionalized adults (>18 years) with a diagnosis of diabetes since at least one year, 
receiving a prescription for oral anti-diabetic medications (OAD), insulin, glycemic strips or 
glucose meter, were eligible and recruited by community-based pharmacies during the summer 
of 2011 [17]. Patients residing outside the canton of Vaud, not speaking or understanding 
French well enough, or those presenting cognitive impairment were excluded, as well as women 
with gestational diabetes. 
Measures 
 
A 20-items French version of the PACIC questionnaire (five-point response scale, 1=never to 
5=always) was used. We translated and culturally adapted the English PACIC version in a 
structured approach, using forward and backward translations and following WHO [18] 
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guidelines for such processes. First, two collaborators fluent both in French and English 
prepared a French version of the questionnaire that was discussed by a group of experts. After 
reaching consensus on a first French version, back translation was performed by a professional 
English-native translator. The expert group then compared the original and back-translated 
English versions, resolved discrepancies and agreed on a version that was tested among 10 
various patients with diabetes.  
Other self-reported data included patients’ socio-demographics and health information: age, 
gender, socio-economic and insurance status, citizenship, place of residence, smoking status, 
weight and height, number of comorbidities, generic and disease-specific health-related quality 
of life, diabetes treatment, and ten process of care indicators (past 12 months HbA1C check 
among those who reported knowing what HbA1C was, eye control by ophthalmologist, 
microalbuminuria check, feet examination by physician, lipid test, blood pressure measure, 
weight measure, influenza immunization, physical activity recommendations, written or verbal 
diet recommendations). We also collected data on proposal to participate in, and effective 
participation in self-management education classes, as well as glucose self-monitoring. Finally, 
we also asked patients to rate their overall care satisfaction level. 
Statistical analysis 
 
First, we conducted descriptive analyses to characterize participants and check data quality of 
each of the 20 PACIC items (mean, standard deviation, median, distribution by category (floor 
and ceiling effects), percentage of missing values). Then, we tested all the models described in 
published PACIC validation studies (Appendix A): model with original five dimensions 
[4,5,6,9,15], two models suggesting two dimensions [10,11], one model with a single dimension 
considering all 20 items [8,14], and one model with a single dimension considering 11 out of the 
20 PACIC items (PACIC-short form) [7,12,14]. Models not reporting enough details for 
replication [13] or not using the full 20 items scale [19] were discarded. Models testing was 
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performed using three different types of confirmatory factor analysis (CFA): 1) CFA based on 
Pearson estimator of variance-covariance matrix, which hypothesizes multivariate normal 
distribution of the data, 2) CFA based on a polychoric correlation matrix (weighted least squares 
estimation method (WLSMV) [20], and 3) CFA based on a likelihood estimation with a 
multinomial distribution for the manifest variables (also called GLLVM [21,22]). These three 
types of CFA make the assumption that the latent variable (patients’ evaluation of their chronic 
illness care) is a continuous and normally distributed concept. These three types of CFA were 
chosen for the following reasons: 1) CFA based  on Pearson estimator because it had often 
been used in other studies and would allow us to compare our results with those previously 
published, even if these models should not be used with ordinal data; 2) CFA considering 
polychoric correlation matrix because it relies on the assumption that the manifest variables 
measured on ordinal scales are indirect observations of underlying normal variables [23]; 3) 
CFA based on likelihood estimations with a multinomial distribution for the manifest variables 
because they do not postulate any joint distribution for the manifest variable since it computes 
the real joint distribution of the data [22].  In addition, these models are recommended in cases 
of asymmetric or multimodal distributions (i.e. in presence of ceiling and floor effects), and 
considering CFA polychoric correlation matrix may lead to biased results [24]. The limitation of 
the use of CFA based on likelihood estimations with multinomial distribution for the manifest 
variables is the absence of goodness of fit measures implemented in current software that help 
comparisons of models.  
Goodness of fit (GoF) of the various CFA models was tested using the Root Mean Square Error 
of Approximation (RMSEA) and Weighted Root Mean Square Residual (WRMR, recommended 
for ordinal data [25]). They were checked jointly because of the sensitivity to misspecified factor 
loading for the RMSEA [26]. The Comparative Fit Index (CFI) was also presented since it is less 
affected by sample size [26,27,28]. Models were considered to present “good fit” if the RMSEA 
was <0.05, [29], WRMR <1.00 [30] and CFI >0.97 [31]. Models were considered to have 
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“acceptable fit” if RMSEA were between 0.05 and 0.08 and CFI between 0.95 and 0.97. Full 
Information Maximum Likelihood (FIML) estimation, which uses raw data as input and all 
available data information, was used to handle missing data for CFA based on Pearson 
estimator of variance-covariance matrix and for GLLVM. For CFA based on a polychoric 
correlation matrix, models were computed on the available data; multiple imputation of missing 
data using Baysian analysis was also performed. 
Finally, we explored associations between the one dimension PACIC score (11 items) and other 
variables hypothesized to be related to, or already shown to be related to it. Pearson or 
Spearman correlations were used to test the association between PACIC and continuous 
variables, t-test for independent groups, or Mann–Whitney U test (when extreme values) for 
categorical variables. Stata 12 was used for most statistical analysis; Mplus 5.0 [20] was used to 
run CFA.  
 
Results 
 
Sample 
The study population is described in Table 1. Mean age was 64.4 years and 59% were men. 
Smokers represented 16% of respondents, and 82% were either overweight or obese. Type 2 
and Type 1 diabetes was reported by 69% and 18% of patients, respectively, while diabetes 
type remained undetermined for almost 20% of patients. At least one complication of diabetes 
was reported by nearly half of all patients.  
 
 
PACIC scores 
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Table 2 provides descriptive results of PACIC items. While 77% of respondents completed all 
items of the questionnaire, the number of missing values varied between 6% and 12%. The 
percentage of respondents who ticked the lowest answering category (floor effect) varied from 
7% to 67%, and was higher than 30% for 12 out of the 20 items. Ceiling effects were less 
marked (4% to 46% of respondents chose the highest answering category, and 5 out of 20 
items presented ceiling effects > 30%).  
 
 
PACIC structure 
The results of CFA considering polychoric correlations on the available data are presented in 
Table 3 (results on imputed data (not shown) are almost similar). They show that even though 
loadings of all five models were relatively high, the only model showing acceptable to good fit 
was the 11-items single dimension model (RMSEA <0.08, WRMR <.1.00, CFI >0.97). Similar 
results were obtained with CFA based on likelihood estimations with multinomial distribution for 
the manifest variables, although slightly higher loadings were found for those items presenting 
the strongest floor or ceiling effects (items 10 and 17; differences lower than 0.10). The 11-items 
single dimension model was also shown to be the best of the five tested models when CFA on 
Pearson estimator of variance matrix was used. This was true in terms of goodness of fit 
(RMSEA is <0.08 and CFI >0.95) only, since loadings were all shown to be lower than those of 
the CFA on polychoric correlation. As expected, conducting CFA analyses with a model for 
multivariate data while data are ordinal, underestimated correlations (results not shown). For 
those interested, the correlation matrix is available on table 4 (polychoric correlations in the 
lower triangle and Pearson correlations in the upper triangle). 
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Relationship of factorial score of PACIC short form and variables of the field 
The single 11-items dimension score was retained for these analyses. Respondents were 
significantly more likely to report higher PACIC scores when treated with insulin, performing 
glucose self-monitoring, being aware of HbA1C, having had feet, eyes or microalbuminuria  
annual checks, having been proposed to attend, or participated, to education classes, having 
received physical activity or diet recommendations.  PACIC factorial 11-items score was also 
significantly associated with age and overall care satisfaction (results not shown). There were 
no significant differences for gender, education, number of comorbidities, annual blood 
pressure, weight, and lipid measures. 
 
Discussion 
 
The results of this study showed that among the several PACIC models proposed in the 
literature, only the one dimension structure using 11 of the 20 PACIC items (PACIC short-form) 
presented appropriate model fit in addition to high loadings. Other published models, including 
the originally described five dimensions structure, were discarded because of poor statistical 
fits.  
 
There are several explanations to the lack of consensus of results regarding the structure of the 
PACIC instrument across validation studies. Firstly, it may be possible that the initial five 
dimensions structure proposed by Glasgow was not the appropriate one, and that the PACIC 
contained less dimensions. In fact, Glasgow emphasized that the dimensions were constructed 
a priori, on the basis of the CCM key elements. He also pointed out that the inter-correlations 
among the PACIC dimensions could make it difficult to distinguish between them; this issue is 
supported statistically. Indeed, since the PACIC items are measured on an ordinal scale, using 
inappropriate models can lead to underestimating correlations and to the selection of too many 
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dimensions [7]. In addition, several published models supported the idea of an instrument 
presenting fewer than five dimensions [7,8,10,11,13,15]. Secondly, the inappropriate choice of 
statistical tools and parameters considered to assess the quality of the models may have 
affected results. Actually, several studies used CFA for multivariate normal data despite the 
presence of ordinal data; this may not only underestimate correlation but also impact the 
magnitude of the dimensions’ loadings [7]. As a matter of fact, results of the three types of CFA 
were close, but loadings of the multivariate normal model were the lowest. This emphasizes the 
point that both the choice of statistical tools and the criteria of model selection may influence 
estimations of the elements of the models. In addition, considering the magnitude of loadings 
only, as selection criteria, is wrong since it is not a measure of goodness of fit (i.e. a measure of 
how well the model fits the observed data). Interestingly, all studies supporting the five 
dimensions structure of the PACIC described either only loadings and no GoF [5,6], or GoF that 
was non-satisfactory [4]. Furthermore, most studies reporting loadings jointly with GoF, as 
should be done, rejected the five dimensions structure of the PACIC [8,9,13,15] or sustained a 
one dimension model [7,8,14]. Thirdly, some studies reporting CFA results used samples 
smaller than the minimal 10 responses by item rule of thumb. Indeed, researchers should 
consider data sets including at least 200 patients while analyzing the structure of a 20-items 
instrument; required sample sizes should even be larger when using ordinal data, and samples 
of about 300 was suggested by some authors [32]. While two of the three studies favoring the 
PACIC five dimensions structure did not reach the minimal number of 200 patients, none of 
these three studies reached the target of 300 patients (n=100 [5];n= 266 [4]; n= 165 [6]). All 
other studies showing less than five dimensions used sample sizes greater than 300. 
 
These three reasons suggest that the PACIC instrument does not present a five dimensions 
structure. They also concur with studies indicating structures composed of one or two 
dimensions, that we also considered in our analyses. The tests of both models proposing two 
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dimensions structures [10,11] showed that while loadings were good, model fits were largely 
unacceptable. We also tested the 20-items single dimension model showing acceptable model 
fits in two studies [8,14]. Unfortunately, we did not find similar results. Finally, the one dimension 
model considering 11 out of the 20 PACIC items, tested in three studies and showing 
acceptable fits [7,12,14], was the model that fitted our data best. Therefore, all these results 
converged towards a single dimension structure comprised of all 20, or only 11, items.  
 
The heterogeneity of structure results could also be linked to methodological considerations 
other than statistical ones. In fact, the PACIC versions used were not always identical, in terms 
of anchoring response categories (“almost always and almost never” versus “always and 
never”) and of number of response modalities (5-points versus 11-points). This could potentially 
affect the number of described dimensions. However, published results did not appear to 
depend on these differences since, for example, the one dimension structure was validated both 
with 5- [14] and 11-points scales [7,8]. Also, studies suggesting a five dimensions structure 
considered both the “almost never” to “almost always” [4,6] and “never” to “always” [5] 
anchoring response categories. 
 
The diversity of healthcare contexts, cultures and types of chronic illnesses may also have 
affected validation results. Evidence from studies favoring the single dimension structure (20 
items - long or 11 items - short form) suggests that it is not the case. In fact, this single 
dimension was found in a variety of countries such as the United States [7,8], Germany [12], the 
Netherlands [14], and Switzerland, and with patients presenting different chronic diseases 
(diabetes [7,8], cardiovascular diseases [14], non-specific chronic illnesses [12]). 
 
The strength of this study are the fact that 1) we used a single dataset to test all published 
validation models, 2) we used statistical tools appropriate for ordinal data, and 3) we presented 
model fits. The interpretation of these results should nevertheless take into consideration the 
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following limitations. First, we did not aim to find the true underlying structure of the PACIC, but 
rather to disentangle dimensions focusing on published models. Therefore, we emphasized the 
analysis of the structure of the PACIC and not its construct validity, hypothesizing that the latter 
was appropriate. As suggested by Gugiu et al. [8] and Spider et al. [33], we strongly encourage 
researchers to focus future studies on the construct validity of the PACIC instrument. Second, 
we employed a newly developed French version of the PACIC. However, we strictly followed the 
translation and adaptation of questionnaires procedures, and our results were similar to others; 
this suggests that results do not depend on healthcare contexts, cultures or chronic diseases 
considered. Third, we did not perform test-retest measures that would have allowed the 
assessment of the reliability of the PACIC French version. Finally, this instrument, which relates 
to the past six months and uses a five-point response scale varying from never to always, may 
not be easy to use for patients visiting their family doctor rather rarely (a few times a year, for 
example) and not seeing any other healthcare professional during that same period. Indeed, it 
may be difficult to decide whether an event happening once during six months represents a 
frequency that should be considered as “sometimes”, “most of the time” or “always” [8,33]. This 
may be particularly true in contexts which have not yet implemented new models of care for 
patients with chronic diseases, and therefore do not offer integrated multidisciplinary care. One 
way to bypass this could be to replace the original five-point scale by a count of time each 
situation occurred, which may be easier to use. 
 
Conclusion 
We showed that among PACIC published validation models, the one considering 11 items in a 
single dimension appeared to best fit data. Also, our results suggested that the lack of 
consensus on the PACIC structure was linked to statistical problems rather than differences in 
healthcare contexts or cultures. To get an overall picture of experiences of people receiving 
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care for chronic diseases, a single score might be used instead of the five previously described 
dimensions. This could be done in complement to the consideration of single item results.  
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Tables 
 
Table 1: Characteristics of participants (n= 406 diabetic patients) 
 
 
Age (n=406) 
 
mean (SD) : 64.4 (11.4) 
Women (n=406) 40.6% 
Civil status (n=403)  
Single 8.7% 
Married/partnership 62.5% 
Divorced/separated/widowed 28.8% 
Education (n=392)   
Primary 19.1% 
Secondary 55.6% 
Tertiary 25.3% 
Employment status (n=394)  
Full-time 25.1% 
Part-time 9.1% 
Retired 55.6% 
Unemployment/handicapped/student 5.8% 
Stay-at-home 4.3% 
Place of residence (n=399)  
Urban 38.9% 
Semi-urban 27.1% 
Rural 34.1% 
Current smoking (n=398) 16.3% 
BMI (n=378)  
Overweight and obese 82.0% 
Self-reported health (n=398)  
Excellent/very good 15.9% 
20 
 
Good 64.3% 
Medium/poor 19.9% 
Type of diabetes (n=406)  
Type 1 12.8% 
Type 2 68.5% 
Undetermined 18.7% 
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Table 2: Data quality of the 20 PACIC items 
          
 
   
 
Percentages 
 
   
 
Response categories  
 
 
 
Item Mean (SD) Median 
Never*  
1 
 
Generally 
not  
2 
Sometimes  
3 
Most 
of the 
time  
4 
Always**  
5 
 
Missing 
values 
          
          
1 3.1 (1.6) 3 27.8 10.2 15.2 15.7 31.2 5.9 
2 2.4 (1.5) 2 44.8 10.9 19.2 12.3 12.8 7.6 
3 3.3 (1.5) 3 20.4 11.6 19.3 17.5 31.2 6.9 
4 2.2 (1.4) 2 48.4 10.6 20.4 10.9 9.8 6.9 
5 4.1 (1.2) 4 7.3 3.4 8.7 35.1 45.5 12.3 
6 3.7 (1.3) 4 12.1 6.8 15.8 28.1 37.3 6.2 
7 2.8 (1.5) 3 28.3 13.9 21.9 18.9 17.1 7.6 
8 2.9 (1.4) 3 22.6 13.0 26.8 22.6 15.1 7.1 
9 2.2 (1.5) 1 54.7 8.6 12.1 12.6 12.1 8.1 
10 1.8 (1.2) 1 64.7 10.9 13.0 4.8 6.6 7.1 
11 2.8 (1.4) 3 28.4 11.1 25.8 19.5 15.3 6.4 
12 3.8 (1.3) 4 13.2 3.4 15.6 29.8 38.0 6.7 
13 2.8 (1.6) 3 36.8 8.9 14.1 18.5 21.7 5.7 
14 2.7 (1.5) 3 35.3 11.3 17.5 18.6 17.3 5.9 
15 2.6 (1.4) 3 34.7 15.1 18.5 19.8 11.9 6.9 
16 2.1 (1.3) 1 52.9 13.8 15.3 11.1 6.9 6.9 
17 1.7 (1.1) 1 67.1 11.8 12.3 5.4 3.5 7.9 
18 2.2 (1.4) 2 49.2 11.4 22.2 7.7 9.5 6.9 
19 3.0 (1.6) 3 30.3 7.4 19.8 17.9 24.5 6.7 
20 2.4 (1.6) 2 47.0 9.6 14.1 13.3 16.2 7.1 
          
 
*Floor effect; **Ceiling effect; SD: standard deviation 
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Table 3 : Loadings and model fits of the five tested models (CFA based on polychoric correlation matrix)  
                                                
 
Model 1* 
(n=392) 
 
Model 2** 
(n=392) 
 
Model 3† 
(n=392) 
 
Model 4‡ 
(n=392) 
 
Model 5§ 
(n=390) 
 
          
 
    
 
    
 
  
 
  
                Item Dim 1 Dim 2 Dim 3 Dim 4 Dim 5 
 
Dim 1 Dim2 
 
Dim 1 Dim2 
 
Dim 1 
 
Dim 1 
                                
                1 0.82 
     
0.73 
  
0.73 
  
0.72 
 
  
2 0.89 
     
0.79 
  
0.79 
  
0.77 
 
0.70 
3 0.78 
     
0.69 
  
0.69 
  
0.67 
 
  
4 
 
0.70 
     
0.71 
  
0.67 
 
0.65 
 
  
5 
 
0.64 
    
0.60 
  
0.60 
  
0.59 
 
0.55 
 6 
 
0.87 
    
0.80 
  
0.81 
  
0.78 
 
  
7 
  
0.83 
   
0.83 
   
0.84 
 
0.82 
 
  
8 
  
0.83 
   
0.83 
   
0.84 
 
0.82 
 
0.79 
9 
  
0.72 
    
0.77 
  
0.72 
 
0.71 
 
0.72 
10 
  
0.73 
    
0.77 
  
0.73 
 
0.72 
 
0.60 
11 
  
0.73 
   
0.74 
   
0.74 
 
0.72 
 
0.72 
12 
   
0.64 
  
0.62 
  
0.62 
  
0.60 
 
  
13 
   
0.84 
  
0.80 
  
0.81 
  
0.79 
 
0.82 
14 
   
0.79 
  
0.76 
  
0.77 
  
0.75 
 
0.79 
15 
   
0.85 
  
0.81 
  
0.82 
  
0.80 
 
0.83 
16 
    
0.61 
  
0.61 
  
0.58 
 
0.56 
 
0.59 
17 
    
0.87 
  
0.84 
  
0.81 
 
0.80 
 
  
18 
    
0.64 
  
0.63 
  
0.60 
 
0.59 
 
  
19 
    
0.75 
  
0.74 
  
0.70 
 
0.69 
 
0.66 
20 
    
0.75 
  
0.75 
  
0.70 
 
0.69 
 
  
               
  
                               
CFI 0.879 
 
0.871 
 
0.842 
 
0.828 
 
0.977 
RMSEA 0.115 
 
0.117 
 
0.129 
 
0.136 
 
0.061 
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WRMR 1.364 
 
1.446 
 
1.577 
 
1.652 
 
0.736 
                            
CFI: Comparative Fit Index; RMSEA: Root Mean Square Error of Approximation, WRMR: Weighted Root Mean Square Residual 
*Glasgow [4]: The original five dimensions structure 
**Taggart  [10]: a two dimensions structure 
†Gensichen [11]: a two dimensions structure 
‡Gugiu [8]: a single dimension structure 
§Gugiu [7]: a single dimension structure considering 11 out of the 20 items  
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Table 4: Correlation matrix of the 20 items of the PACIC: polychoric correlations in the lower triangle and 
Pearson correlations in the upper triangle  
 
 
0.649 0.468 0.356 0.348 0.438 0.459 0.425 0.409 0.303 0.405 0.314 0.465 0.451 0.367 0.292 0.332 0.243 0.364 0.362 
0.766 
 
0.558 0.370 0.290 0.471 0.535 0.442 0.390 0.306 0.466 0.324 0.471 0.477 0.509 0.320 0.375 0.275 0.365 0.362 
0.556 0.675 
 
0.349 0.428 0.431 0.501 0.451 0.320 0.234 0.475 0.341 0.351 0.331 0.469 0.260 0.266 0.240 0.321 0.422 
0.451 0.454 0.430 
 
0.283 0.428 0.437 0.518 0.505 0.349 0.343 0.317 0.386 0.379 0.329 0.316 0.369 0.363 0.353 0.291 
0.428 0.359 0.492 0.339 
 
0.561 0.349 0.417 0.218 0.187 0.411 0.387 0.351 0.361 0.346 0.254 0.172 0.205 0.284 0.246 
0.523 0.604 0.512 0.557 0.643 
 
0.590 0.605 0.342 0.309 0.506 0.379 0.467 0.464 0.468 0.294 0.323 0.333 0.395 0.354 
0.539 0.629 0.594 0.518 0.431 0.698 
 
0.689 0.480 0.364 0.491 0.374 0.532 0.490 0.586 0.353 0.366 0.330 0.381 0.432 
0.506 0.529 0.521 0.613 0.504 0.694 0.760 
 
0.497 0.374 0.513 0.389 0.533 0.516 0.551 0.346 0.410 0.400 0.432 0.414 
0.524 0.484 0.406 0.610 0.279 0.463 0.579 0.620 
 
0.385 0.296 0.303 0.527 0.411 0.441 0.431 0.413 0.270 0.387 0.342 
0.400 0.416 0.310 0.462 0.218 0.449 0.474 0.498 0.507 
 
0.347 0.266 0.390 0.328 0.343 0.234 0.696 0.434 0.326 0.217 
0.478 0.549 0.548 0.423 0.492 0.609 0.580 0.596 0.374 0.447 
 
0.463 0.500 0.414 0.535 0.323 0.382 0.394 0.356 0.405 
0.398 0.410 0.414 0.393 0.476 0.451 0.461 0.474 0.403 0.357 0.546 
 
0.491 0.371 0.407 0.183 0.215 0.178 0.328 0.263 
0.542 0.565 0.423 0.468 0.455 0.584 0.626 0.621 0.642 0.504 0.603 0.617 
 
0.569 0.550 0.350 0.367 0.349 0.449 0.412 
0.531 0.568 0.398 0.464 0.424 0.554 0.567 0.594 0.500 0.440 0.490 0.466 0.665 
 
0.619 0.391 0.410 0.382 0.416 0.408 
0.443 0.595 0.555 0.404 0.410 0.573 0.668 0.632 0.542 0.440 0.617 0.478 0.652 0.703 
 
0.399 0.459 0.368 0.466 0.499 
0.376 0.397 0.330 0.386 0.315 0.392 0.442 0.427 0.532 0.334 0.403 0.210 0.444 0.476 0.490 
 
0.342 0.297 0.304 0.314 
0.453 0.491 0.355 0.477 0.174 0.461 0.486 0.545 0.541 0.820 0.503 0.253 0.477 0.535 0.581 0.468 
 
0.497 0.394 0.344 
0.296 0.339 0.293 0.455 0.190 0.420 0.396 0.473 0.345 0.571 0.467 0.186 0.422 0.455 0.428 0.381 0.638 
 
0.375 0.333 
0.431 0.458 0.390 0.446 0.338 0.495 0.458 0.506 0.503 0.433 0.428 0.387 0.537 0.509 0.559 0.382 0.537 0.467 
 
0.589 
0.456 0.451 0.501 0.375 0.304 0.471 0.527 0.509 0.455 0.312 0.484 0.318 0.527 0.516 0.601 0.399 0.465 0.419 0.709 
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Appendix 
Appendix A: Summary of PACIC validation analyses, as reported in published papers 
Author 
Country 
Disease(s)  
targeted 
(sample  
size) 
 
PACIC 
version 
Type of 
analysis 
Nb of 
dim. 
Alpha 
cronbach 
Test-
retest 
Data Quality 
Ceiling effect (CE) 
Floor effect (FE) Missing 
(M) 
Goodness of fit (GoF) 
Loadings (L) 
Other (O) 
Associations 
with other 
variables 
         
Glasgow  
USA 
Several 
chronic 
diseases 
(n=266) 
[4] 
Original 
validation* 
 
CFA 5 0.77 to 
0.93 
r=0.47 to 
0.68 
(n=52 to 
57) 
CE: none 
FE: yes, but magnitude not 
specified 
M: 4% 
 
GoF: Moderate fit (non-
normed fit index=0.87 and 
comparative fit index to 
assess model fit=0.89) 
L: 0.54 to 0.89 with 3 items 
<0.70 
O: 62% to 74% of 
explained variance 
 
With†: age, gender, 
number of chronic 
conditions 
 
None‡: education, overall 
health, years since 
diagnosis  
         
Aragones  
USA 
Diabetes 
(n=100) 
[5] 
 
Spanish** CFA 5 >0.60 r=0.77 
(n=20) 
CE: none 
FE: none 
M:NA 
GoF: NA 
L: 13 items >0.70, 1 
item<0.60 (most items 
correlated highly on 
proposed scales) 
None‡: comorbidities, age, 
education, country of 
origin, years living in the 
USA 
          
Wensing  
Netherlands 
Diabetes or 
COPD 
(n=165) 
 [6] 
Dutch 
(long/short 
form) * 
PCA 5 0.71 to 
0.93 
NA CE: 10% to 54% with  
>30% for 6 items 
FE: 7% to 76% with >30% 
for 11 items 
M: 22% to 35% 
GoF: NA 
L:PA,DS & PS: 0.39 to 
078; GS & FC: not ok 
O: 70% explained 
variance, KMO=0.844, 
Bartlett's test of sphericity: 
p<0.001 
 
With†: EUROPEP score 
         
Gugiu  
USA 
Type 2 
diabetes (S1 
n=529, S2 
n=361) 
[7] 
English 
short form 
(11 items) 
*** 
 
 
EFA within 
CFA (long 
form, S1); CFA 
on polychoric 
correlation 
matrix (short 
form, S2) 
 
1 0.96 
(ordinal 
omega) 
r=0.64 
(n=250) 
Response modalities 
recoded into 3 categories  
due to moderate floor and 
ceiling effects 
GoF: good for short form 
L: NA 
None‡: age, gender, 
education, income, marital 
status, insurance type, 
blood pressure, HbA1c, 
LDL cholesterol, 
microalbumin 
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Author 
Country 
Disease(s)  
targeted 
(sample  
size) 
 
PACIC 
version 
Type of 
analysis 
Nb of 
dim. 
Alpha 
cronbach 
Test-
retest 
Data Quality 
Ceiling effect (CE) 
Floor effect (FE) Missing 
(M) 
Goodness of fit (GoF) 
Loadings (L) 
Other (O) 
Associations 
with other 
variables 
           
Gugiu  
USA 
Type 2 
diabetes 
(n=529) 
[8] 
PACIC 
(long/short 
form) *** 
 
CFA 
(polychoric 
correlation 
matrix) 
 
EFA on 
polychoric 
correlation 
matrix 
 
NB: response 
modalities 
recoded into 3 
categories 
 
1 0.97 
(ordinal 
omega) 
NA CE: 43% 
FE: 24% 
M:0.2% to 2.8% (8.9% at 
least one missing: multiple 
imputation performed) 
GoF: poor for 5 
dimensions 
L: NA 
O: 1 to 3 dimensions 
retained, 1 dimension more 
reliable 
None‡: clinical indicators 
         
Maindal  
Denmark 
Diabetes 
(n=481) 
[9] 
Danish 
PACIC** 
CFA for 
categorical 
measures 
5 0.71 to 
0.94 
NA CE: 4.0% to 40.4% with 
>15% for 12 items 
FE: 2.7% to 69.2%, with 
>15% for 17 items 
M: 0.5% to 2.9%  
 
GoF: bad fits (chi2, CFI, 
RMSEA, WRMR not good) 
L: 0.31 to 0.77 (<0.60 for 8 
items) 
 
None‡: age, gender 
         
Taggart  
Australia 
Diabetes, 
IHD, HBP (S1 
n=2552, S2 
n=758) 
[10] 
 
Original 
PACIC** 
EFA 2 0.88 to 
0.94 
NA CE: NA 
FE: NA 
M: 27% (S1) and 21% (S2) 
(5% with at least 3 items) 
GoF: NA 
L: 0.50 to 0.81 with >0.60 
for 15 items (both samples) 
O: 59% (S1), 61% (S2) of 
explained variance 
 
With†: education, 
employment, marital 
status, hypertension, 
duration of  disease 
         
Gensichen  
Germany 
Major 
depression 
(n=442) 
[11] 
 
German 
PACIC* 
EFA 2 0.45 to 
0.91 
NA CE: 12.9%(PA),8.9% 
(PS) 
FE:4.6%(GS) 
M: 0.7% to 5.4% 
 
GoF: NA 
L: PA, DS and PS on the 
first factor. GS and FC on 
the second factor 
O: 46.5% of explained 
variance 
With†: EUROPEP 
None‡: age, gender, 
education, comorbidities, 
PHQ9  
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Author 
Country 
Disease(s)  
targeted 
(sample  
size) 
 
PACIC 
version 
Type of 
analysis 
Nb of 
dim. 
Alpha 
cronbach 
Test-
retest 
Data Quality 
Ceiling effect (CE) 
Floor effect (FE) Missing 
(M) 
Goodness of fit (GoF) 
Loadings (L) 
Other (O) 
Associations 
with other 
variables 
Goetz  
Germany 
Chronic 
illnesses 
(n=264) 
[12] 
German 
PACIC 
short 
form*** 
PCA 1 0.87 NA CE: 18.1% to 58.9% with 
>20% for 9 of 11 items 
FE: 1.2% to 43.3% with 
>20% for 7 of 11 items 
M: 4.2% to 12.5% 
 
 
GoF: NA 
L: 0.52 to 0.85 
O: 48% of explained 
variance, KMO=0.90, 
Bartlett's test of sphericity: 
p<0.001 
None‡: comorbidities 
         
Drewes  
Netherlands 
Diabetes 
(n=1547) 
[13] 
Dutch 
PACIC* 
EFA 
(polychoric 
correlation 
matrix, split 
half sample)  
 
CFA 
(polychoric 
correlation 
matrix, split 
half sample) 
 
1, 2, 
3, 4 
and 5 
dimen
sions 
0.92 NA CE: NA 
FE: NA 
M: 20% (multiple 
imputation performed) 
GoF: none of the models 
have acceptable fits: 
RMSEA>0.10  
GoF of other structures: no 
acceptable fits 
L: NA  
O: EFA, no clear structure 
 
With†: age, education and 
duration of diabetes 
 
          
Cramm  
Netherlands 
CVD  
(n=1167) 
[14] 
Dutch 
PACIC 
(long/short 
form) * 
 
CFA both on 
full data and 
imputed data; 
test-retest 
(n=585) 
 
1 0.88 to 
0.93 
NA CE: NA 
FE: NA 
M: 7.9% to 9.7%, (mean 
imputation performed) 
GoF: acceptable fit 
L: NA 
NA 
         
Rick  
United-
Kingdom 
Long term 
conditions 
(n=1846) 
[15] 
Original 
PACIC* 
 
CFA both on 
full data and 
imputed data 
5 0.68 to 
0.94 
NA CE: none 
FE: 20.9% (PA), 14.2% 
(GS), 14.7% (PS), 30.4% 
(FC) 
M: 9.6% to 15.9%, 14.6% 
full PACIC missing 
(multiple regression 
imputation performed) 
GoF: no acceptable fit 
L: NA 
O: Structure not found 
With†: age, gender, shared 
decision making, 
assessment of quality of 
care, patient satisfaction 
None‡: number of 
conditions, contact with a 
GP, main professional 
responsible for care 
         
 
*  response scale: from 1:almost never to 5 almost always 
** response scale: from 1:never to 5:always 
*** 11-points scale, from 0% to 100% 
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PACIC original dimensions: PA: patient activation; DS: delivery system; GS: Goal setting; PS: Problem solving; FC: Follow up and Co-ordination  
EFA: exploratory factorial analysis; CFA: confirmatory factorial analysis; PCA: principal component analysis; KMO: Kaiser-Meyer- Olkin test; NA: not available 
CE: ceiling effect; FE: floor effect; M: missing data; S1: sample 1; S2: sample 2; HbA1c: glycated hemoglobin; LDL: low density lipoprotein (cholesterol); EUROPEP: European patient 
evaluation of general practice care; PHQ9: Patient health Questionnaire; GP: general practitioner; IHD: ischemic heart diseases; COPD: chronic obstructive pulmonary disease; HBP: 
high blood pressure; CVD: cardio-vascular diseases 
†: association shown between PACIC score and the listed variables; ‡: associations were not detected between PACIC scores and the listed variables 
 
 
 
